A5023294477- Genetic factors in colorectal cancer
- Cancer Genomics and Diagnostics
- Colorectal Cancer Treatments and Studies
- Genomics and Rare Diseases
- Clinical practice guidelines implementation
- Health Systems, Economic Evaluations, Quality of Life
- Colorectal and Anal Carcinomas
- Ethics in Clinical Research
- Biomedical Text Mining and Ontologies
- Lung Cancer Treatments and Mutations
- BRCA gene mutations in cancer
- Genetics, Bioinformatics, and Biomedical Research
- Colorectal Cancer Surgical Treatments
- Colorectal Cancer Screening and Detection
- Health Policy Implementation Science
- Epigenetics and DNA Methylation
- Renal Transplantation Outcomes and Treatments
- Hematopoietic Stem Cell Transplantation
- Health Sciences Research and Education
- Organ Transplantation Techniques and Outcomes
- Bacterial Identification and Susceptibility Testing
- Chronic Myeloid Leukemia Treatments
- Lymphoma Diagnosis and Treatment
- Single-cell and spatial transcriptomics
- Primary Care and Health Outcomes
Therapeutic Guidelines
2023
Roswell Park Comprehensive Cancer Center
2017
University of Nebraska Medical Center
2017
University of Florida
2017
UCLA Medical Center
2017
University of Colorado Denver
2017
Los Angeles Medical Center
2017
University of Pittsburgh
2007
Context.— In 2013, an evidence-based guideline was published by the College of American Pathologists, International Association for Study Lung Cancer, and Molecular Pathology to set standards molecular analysis lung cancers guide treatment decisions with targeted inhibitors. New evidence has prompted evaluation additional laboratory technologies, targetable genes, patient populations, tumor types testing. Objective.— To systematically review update 2013 affirm its validity; assess new...
Objectives.— To develop evidence-based guideline recommendations through a systematic review of the literature to establish standard molecular biomarker testing colorectal cancer (CRC) tissues guide epidermal growth factor receptor (EGFR) therapies and conventional chemotherapy regimens. Methods.— The American Society for Clinical Pathology, College Pathologists, Association Molecular Oncology convened an expert panel patients with CRC. A comprehensive search that included more than 4,000...
Abstract Objectives: To develop evidence-based guideline recommendations through a systematic review of the literature to establish standard molecular biomarker testing colorectal cancer (CRC) tissues guide epidermal growth factor receptor (EGFR) therapies and conventional chemotherapy regimens. Methods: The American Society for Clinical Pathology, College Pathologists, Association Molecular Oncology convened an expert panel patients with CRC. A comprehensive search that included more than...
e23157 Background: Precision medicine holds promise for improving cancer care, yet significant challenges persist in implementing multigene NGS testing and incorporating targeted therapies community settings. To better understand these issues, an implementation science framework was used to identify key barriers facilitators inform future QI projects. Methods: The study involved a retrospective review of biomarker patterns across three centers, coupled with stakeholder interviews process...